Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Concept/Terms
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 25 | 28 |
| 1994 | 4 | 12 | 16 |
| 1995 | 4 | 16 | 20 |
| 1996 | 7 | 36 | 43 |
| 1997 | 14 | 21 | 35 |
| 1998 | 6 | 37 | 43 |
| 1999 | 7 | 33 | 40 |
| 2000 | 7 | 33 | 40 |
| 2001 | 8 | 24 | 32 |
| 2002 | 4 | 7 | 11 |
| 2003 | 2 | 5 | 7 |
| 2004 | 0 | 4 | 4 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 6 | 8 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 4 | 6 |
| 2010 | 4 | 1 | 5 |
| 2011 | 5 | 5 | 10 |
| 2012 | 1 | 0 | 1 |
| 2013 | 8 | 5 | 13 |
| 2014 | 11 | 7 | 18 |
| 2015 | 9 | 3 | 12 |
| 2016 | 3 | 6 | 9 |
| 2017 | 2 | 6 | 8 |
| 2018 | 9 | 4 | 13 |
| 2019 | 8 | 7 | 15 |
| 2020 | 7 | 8 | 15 |
| 2021 | 3 | 9 | 12 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 6 | 6 |
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Bayesian modeling of the impact of antibiotic resistance on the efficiency of MRSA decolonization. PLoS Comput Biol. 2023 Oct; 19(10):e1010898.
-
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa. Nat Commun. 2023 Oct 23; 14(1):6392.
-
Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis. Lancet Microbe. 2023 10; 4(10):e790-e799.
-
Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clin Infect Dis. 2023 07 05; 77(Suppl 1):S89-S96.
-
Impact of Respiratory Infection and Chronic Comorbidities on Early Pediatric Antibiotic Dispensing in the United States. Clin Infect Dis. 2023 02 08; 76(3):382-388.
-
CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae. Nat Microbiol. 2023 01; 8(1):28-39.
-
Mass drug administration of azithromycin: an analysis. Clin Microbiol Infect. 2023 Mar; 29(3):326-331.
-
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries. Nat Microbiol. 2022 09; 7(9):1337-1347.
-
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study. Int J Infect Dis. 2022 Sep; 122:313-320.
-
Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger. Int J Infect Dis. 2022 Jun; 119:163-171.